M. Marsden

发表

Human Immunodeficiency Virus Bearing a Disrupted Central DNA Flap Is Pathogenic In Vivo

M. Marsden, J. Zack, 2007, Journal of Virology.

Prodrugs of PKC modulators show enhanced HIV latency reversal and an expanded therapeutic window

T. Chun, M. Marsden, J. Zack, 2020, Proceedings of the National Academy of Sciences.

RNAi-Mediated CCR5 Knockdown Provides HIV-1 Resistance to Memory T Cells in Humanized BLT Mice

D. Elashoff, M. Marsden, J. Zack, 2015, Molecular therapy. Nucleic acids.

Generation of T Lineage Cells from Human Embryonic Stem Cells in a Feeder Free System

O. Yang, M. Marsden, J. Zack, 2009, Stem cells.

Macrophage differentiation from embryoid bodies derived from human embryonic stem cells.

G. Cheng, M. Marsden, J. Zack, 2009, Journal of stem cells.

Contribution of Sex Differences to HIV Immunology, Pathogenesis, and Cure Approaches

M. Marsden, J. Moran, Shireen R. Turner, 2022, Frontiers in Immunology.

HIV cure strategies: a complex approach for a complicated viral reservoir?

M. Marsden, J. Zack, 2019, Future Virology.

Primary Cell Model for Activation-Inducible Human Immunodeﬁciency Virus (cid:1)

M. Marsden, J. Zack, D. Vatakis, 2007 .

Human Immunodeﬁciency Virus Bearing a Disrupted Central DNA Flap Is Pathogenic In Vivo (cid:1)

M. Marsden, J. Zack, 2007 .

Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy

M. Marsden, J. Zack, P. Wender, 2020, Nature Communications.

An immune control model for viral replication in the CNS during presymptomatic HIV infection.

P. Simmonds, R. Brettle, J. Bell, 2006, Brain : a journal of neurology.

Latency reversal plus natural killer cells diminish HIV reservoir in vivo

Jocelyn T. Kim, D. Wodarz, N. Komarova, 2022, Nature communications.

Latency reversal plus natural killer cells diminish HIV reservoir in vivo

Jocelyn T. Kim, D. Wodarz, R. Sun, 2022, Nature Communications.

Humanized Mouse Models for Human Immunodeficiency Virus Infection.

M. Marsden, J. Zack, 2017, Annual review of virology.

Investigation of the genetic and molecular basis of HIV-1 cellular tropism in vivo

Matthew David Marsden, M. Marsden, 2003 .

Disruption of Type I Interferon Induction by HIV Infection of T Cells

G. Cheng, M. Marsden, J. Zack, 2015, PloS one.

Eradication of HIV: current challenges and new directions.

M. Marsden, J. Zack, 2008, The Journal of antimicrobial chemotherapy.

Studies of retroviral infection in humanized mice.

M. Marsden, J. Zack, 2015, Virology.

Experimental Approaches for Eliminating Latent HIV.

M. Marsden, J. Zack, 2015, Forum on immunopathological diseases and therapeutics.

HIV/AIDS eradication.

M. Marsden, J. Zack, 2013, Bioorganic & medicinal chemistry letters.

Establishment and maintenance of HIV latency: model systems and opportunities for intervention.

M. Marsden, J. Zack, 2010, Future virology.

Primary Cell Model for Activation-Inducible Human Immunodeficiency Virus

M. Marsden, J. Zack, D. Vatakis, 2007, Journal of Virology.

Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents

M. Marsden, J. Zack, P. Wender, 2018, Virology.

Benefits and limitations of humanized mice in HIV persistence studies

M. Marsden, 2020, Retrovirology.

Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol.

G. Cheng, L. Su, M. Marsden, 2013, Immunity.

Mosaic Structure of the Human Immunodeficiency Virus Type 1 Genome Infecting Lymphoid Cells and the Brain: Evidence for Frequent In Vivo Recombination Events in the Evolution of Regional Populations

P. Simmonds, R. Brettle, J. Bell, 1999, Journal of Virology.

Double trouble: HIV latency and CTL escape.

M. Marsden, J. Zack, 2015, Cell host & microbe.

Tracking HIV Rebound following Latency Reversal Using Barcoded HIV

Jocelyn T. Kim, R. Sun, Yushen Du, 2020, Cell reports. Medicine.

Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo

T. Chun, M. Marsden, J. Zack, 2013, Proceedings of the National Academy of Sciences.

Designed, Synthetically Accessible Bryostatin Analogues Potently Induce Activation of Latent HIV Reservoirs in vitro

M. Marsden, J. Zack, P. Wender, 2012, Nature chemistry.

HIV Latency in the Humanized BLT Mouse

M. Marsden, J. Zack, M. Kovochich, 2011, Journal of Virology.

Short communication: Activating stimuli enhance immunotoxin-mediated killing of HIV-infected macrophages.

D. Hamer, M. Marsden, J. Zack, 2008, AIDS research and human retroviruses.

Humanized Mouse Model of HIV-1 Latency with Enrichment of Latent Virus in PD-1+ and TIGIT+ CD4 T Cells

A. Haase, David E. Paschon, M. Holmes, 2019, Journal of Virology.

Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs In Vivo

Jocelyn T. Kim, S. Chanda, A. Spivak, 2020, Cell reports. Medicine.

HIV latency is influenced by regions of the viral genome outside of the long terminal repeats and regulatory genes.

M. Marsden, J. Zack, Bryan P. Burke, 2011, Virology.

Secreted factors induced by PKC modulators do not indirectly cause HIV latency reversal

J. A. Moran, Jocelyn T. Kim, A. Ranjan, 2023, Virology.

In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication

T. Chun, M. Marsden, J. Zack, 2017, PLoS pathogens.

OP 2.8 – 00193 Enhancing PKC Modulator HIV Latency Reversing Agents

M. Marsden, J. Zack, P. Wender, 2022, Journal of virus eradication.

Bioengineered Vaults: Self-Assembling Protein Shell–Lipophilic Core Nanoparticles for Drug Delivery

V. Kickhoefer, L. Rome, Z. Zhou, 2014, ACS nano.

Single Mutations in HIV Integrase Confer High-Level Resistance to Raltegravir in Primary Human Macrophages

M. Marsden, J. Zack, C. Kitchen, 2011, Antimicrobial Agents and Chemotherapy.

Activation of Latent HIV Using Drug-Loaded Nanoparticles

M. Marsden, J. Zack, M. Kovochich, 2011, PloS one.

Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy

M. Marsden, J. Zack, P. Wender, 2020, Nature Communications.

Benefits and limitations of humanized mice in HIV persistence studies

M. Marsden, 2020, Retrovirology.

HIV establishes an early foothold.

J. A. Moran, M. Marsden, 2023, Cell host & microbe.

Can macrophages form a latent reservoir of HIV?

M. Marsden, V. Pham, 2021, Future virology.

Virological Evidence Supporting the Use of Raltegravir in HIV Post-Exposure Prophylaxis Regimens

M. Marsden, J. Zack, P. Krogstad, 2012, Antiviral therapy.

HIV latency is influenced by regions of the viral genome outside of the long terminal repeats and regulatory genes.

M. Marsden, J. Zack, Bryan P. Burke, 2011, Virology.

HIV Persistence, Latency, and Cure Approaches: Where Are We Now?

M. Marsden, Nishad S. Maggirwar, Tessa C. Chou, 2024, Viruses.

Neutralizing the HIV Reservoir

M. Marsden, J. Zack, 2014, Cell.